Paper16652145
Cortactin underpins CD44-promoted invasion and adhesion of breast cancer cells to bone marrow endothelial cells.
Hill A and 10 others. Oncogene, 2006. Cited by 106 papers, by iCite.
Cite this record
ConductScience Library. Cortactin underpins CD44-promoted invasion and adhesion of breast cancer cells to bone marrow endothelial cells. Papers, record 16652145. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16652145
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cortactin underpins CD44-promoted invasion and adhesion of breast cancer cells to bone marrow endothelial cells.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bone Marrow | Major topic |
| Breast Neoplasms | Major topic |
| Cell Adhesion | Major topic |
| Cortactin | Major topic |
| Endothelium | Major topic |
| Hyaluronan Receptors | Major topic |
| Neoplasm Invasiveness | Major topic |
| Base Sequence | |
| Blotting, Western | |
| Cell Line, Tumor | |
| DNA Primers | |
| Humans | |
| Immunohistochemistry | |
| Signal Transduction | |
| Transcription, Genetic |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| G0200103 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10657658 | Ras, protein kinase C zeta, and I kappa B kinases 1 and 2 are downstream effectors of CD44 during the activation of NF-kappa B by hyaluronic acid fragments in T-24 carcinoma cells. | J Immunol | 2000 | https://conductscience.org/library/papers/10657658 | PubMed |
| 2 | 16051170 | Cortactin promotes cell motility by enhancing lamellipodial persistence. | Curr Biol | 2005 | https://conductscience.org/library/papers/16051170 | PubMed |
| 3 | 10679362 | How WASP-family proteins and the Arp2/3 complex convert intracellular signals into cytoskeletal structures. | Curr Opin Cell Biol | 2000 | https://conductscience.org/library/papers/10679362 | PubMed |
| 4 | 11113870 | Epidermal growth factor up-regulates CD44-dependent astrocytoma invasion in vitro. | J Pathol | 2000 | https://conductscience.org/library/papers/11113870 | PubMed |
| 5 | 16280034 | Cortactin overexpression results in sustained epidermal growth factor receptor signaling by preventing ligand-induced receptor degradation in human carcinoma cells. | Breast Cancer Res | 2005 | https://conductscience.org/library/papers/16280034 | PubMed |
| 6 | 11231575 | Activation of Arp2/3 complex-mediated actin polymerization by cortactin. | Nat Cell Biol | 2001 | https://conductscience.org/library/papers/11231575 | PubMed |
| 7 | 10666382 | Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. | Am J Pathol | 2000 | https://conductscience.org/library/papers/10666382 | PubMed |
| 8 | 10725329 | Hyaluronic acid (HA) binding to CD44 activates Rac1 and induces lamellipodia outgrowth. | J Cell Biol | 2000 | https://conductscience.org/library/papers/10725329 | PubMed |
| 9 | 8858161 | Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway. | J Cell Biol | 1996 | https://conductscience.org/library/papers/8858161 | PubMed |
| 10 | 10955801 | EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck. | Clin Cancer Res | 2000 | https://conductscience.org/library/papers/10955801 | PubMed |
| 11 | 11956084 | Absence of the CD44 gene prevents sarcoma metastasis. | Cancer Res | 2002 | https://conductscience.org/library/papers/11956084 | PubMed |
| 12 | 16025223 | Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy. | J Mammary Gland Biol Neoplasia | 2005 | https://conductscience.org/library/papers/16025223 | PubMed |
| 13 | 11488992 | Effects of hyaluronan on the invasive properties of human breast cancer cells in vitro. | Int J Exp Pathol | 2001 | https://conductscience.org/library/papers/11488992 | PubMed |
| 14 | 11971857 | Hyaluronan promotes the malignant phenotype. | Glycobiology | 2002 | https://conductscience.org/library/papers/11971857 | PubMed |
| 15 | 11245336 | Expression of CD44 isoforms in infiltrating lobular carcinoma of the breast. | Breast Cancer Res Treat | 2001 | https://conductscience.org/library/papers/11245336 | PubMed |
| 16 | 11084024 | CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic acid-dependent ovarian tumor cell migration. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11084024 | PubMed |
| 17 | 8941660 | Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. | J Clin Invest | 1996 | https://conductscience.org/library/papers/8941660 | PubMed |
| 18 | 9519902 | The ankyrin-binding domain of CD44s is involved in regulating hyaluronic acid-mediated functions and prostate tumor cell transformation. | Cell Motil Cytoskeleton | 1998 | https://conductscience.org/library/papers/9519902 | PubMed |
| 19 | 10978893 | Hyaluronan: a multifunctional, megaDalton, stealth molecule. | Curr Opin Cell Biol | 2000 | https://conductscience.org/library/papers/10978893 | PubMed |
| 20 | 11988077 | Primary arrest of circulating platelets on collagen involves phosphorylation of Syk, cortactin and focal adhesion kinase: studies under flow conditions. | Biochem J | 2002 | https://conductscience.org/library/papers/11988077 | PubMed |
Cited by80
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 106 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41596432 | Bone Metastasis in Estrogen Receptor-Positive Breast Cancer: Molecular Insights and Therapeutic Advances. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41596432 | PubMed |
| 39673684 | Effects of NaV1.5 and Rac1 on the Epithelial-Mesenchymal Transition in Breast Cancer. | Cell Biochem Biophys | 2025 | https://conductscience.org/library/papers/39673684 | PubMed |
| 39430073 | Clinicopathological features associated with CD44 and CD63 expression in breast cancer. | Ecancermedicalscience | 2024 | https://conductscience.org/library/papers/39430073 | PubMed |
| 38736891 | CD44: a cancer stem cell marker and therapeutic target in leukemia treatment. | Front Immunol | 2024 | https://conductscience.org/library/papers/38736891 | PubMed |
| 38727931 | Effects of CD44 siRNA on inhibition, survival, and apoptosis of breast cancer cell lines (MDA-MB-231 and 4T1). | Mol Biol Rep | 2024 | https://conductscience.org/library/papers/38727931 | PubMed |
| 38613804 | The mechanism of USP43 in the development of tumor: a literature review. | Aging (Albany NY) | 2024 | https://conductscience.org/library/papers/38613804 | PubMed |
| 37759500 | Evaluation of Dimercaptosuccinic Acid-Coated Iron Nanoparticles Immunotargeted to Amyloid Beta as MRI Contrast Agents for the Diagnosis of Alzheimer's Disease. | Cells | 2023 | https://conductscience.org/library/papers/37759500 | PubMed |
| 37252376 | ITGB1BP1, a Novel Transcriptional Target of CD44-Downstream Signaling Promoting Cancer Cell Invasion. | Breast Cancer (Dove Med Press) | 2023 | https://conductscience.org/library/papers/37252376 | PubMed |
| 36831511 | CTTN Overexpression Confers Cancer Stem Cell-like Properties and Trastuzumab Resistance via DKK-1/WNT Signaling in HER2 Positive Breast Cancer. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36831511 | PubMed |
| 36505828 | SIRT1, a novel transcriptional downstream target of CD44, linking its deacetylase activity to tumor cell invasion/metastasis. | Front Oncol | 2022 | https://conductscience.org/library/papers/36505828 | PubMed |
| 36137995 | Cav2.2-NFAT2-USP43 axis promotes invadopodia formation and breast cancer metastasis through cortactin stabilization. | Cell Death Dis | 2022 | https://conductscience.org/library/papers/36137995 | PubMed |
| 35805061 | Regulation of Tissue Factor by CD44 Supports Coagulant Activity in Breast Tumor Cells. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35805061 | PubMed |
| 35756640 | PCF11, a Novel CD44-Downstream Transcriptional Target, Linking Its 3'-End Polyadenylation Function to Tumor Cell Metastasis. | Front Oncol | 2022 | https://conductscience.org/library/papers/35756640 | PubMed |
| 35433966 | GeneChip expression profiling identified OLFML2A as a potential therapeutic target in TNBC cells. | Ann Transl Med | 2022 | https://conductscience.org/library/papers/35433966 | PubMed |
| 35204811 | Discovering the Triad between Nav1.5, Breast Cancer, and the Immune System: A Fundamental Review and Future Perspectives. | Biomolecules | 2022 | https://conductscience.org/library/papers/35204811 | PubMed |
| 35164076 | SOD2, a Potential Transcriptional Target Underpinning CD44-Promoted Breast Cancer Progression. | Molecules | 2022 | https://conductscience.org/library/papers/35164076 | PubMed |
| 35090088 | Disruption of the pentraxin 3/CD44 interaction as an efficient therapy for triple-negative breast cancers. | Clin Transl Med | 2022 | https://conductscience.org/library/papers/35090088 | PubMed |
| 33921242 | Targeting the Stromal Pro-Tumoral Hyaluronan-CD44 Pathway in Pancreatic Cancer. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33921242 | PubMed |
| 33810348 | In Silico Design and Selection of New Tetrahydroisoquinoline-Based CD44 Antagonist Candidates. | Molecules | 2021 | https://conductscience.org/library/papers/33810348 | PubMed |
| 33734001 | Tissue factor potentiates adherence of breast cancer cells to human umbilical vein endothelial cells under static and flow conditions. | Cell Adh Migr | 2021 | https://conductscience.org/library/papers/33734001 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD44 | 960 | PubTator's text mining | https://conductscience.org/library/genes/960 | NCBI Gene |
| CTTN | 2017 | PubTator's text mining | https://conductscience.org/library/genes/2017 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16652145
GET https://conductscience.org/api/papers/v1/16652145/references?page=2